Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease

By Nitta Kosaku   Iimuro Satoshi   Imai Enyu   Matsuo Seiichi   Makino Hirofumi   Akizawa Tadao   Watanabe Tsuyoshi   Ohashi Yasuo   Hishida Akira  

Clinical and Experimental Nephrology, Vol. 17, Iss. 5, 2013-10 ,pp. : 730-742

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin D deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease

By Lai Silvia   Coppola Bettina   Dimko Mira   Galani Alessandro   Innico Georgie   Frassetti Nicla   Mariotti Amalia  

Renal Failure, Vol. 36, Iss. 1, 2014-02 ,pp. : 58-64

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease

By Ulusoy Şükrü   Özkan Gülsüm   Örem Cihan   Kaynar Kübra   Koşucu Polat   Kırış Abdulkadir  

Renal Failure, Vol. 32, Iss. 8, 2010-09 ,pp. : 913-917

Informa Healthcare

Access to resources Recommend Favorite

The Prevalence of Left Ventricular Hypertrophy in Chinese Hemodialysis Patients Is Higher Than That in Peritoneal Dialysis Patients

By Tian Jun-Ping   Wang Tao   Wang Hong   Cheng Li-Tao   Tian Xin-Kui   Lindholm Bengt   Axelsson Jonas   Du Feng-He  

Renal Failure, Vol. 30, Iss. 4, 2008-05 ,pp. : 391-400

Informa Healthcare

Access to resources Recommend Favorite

The Relationship of Visfatin Levels with Insulin Resistance and Left Ventricular Hypertrophy in Peritoneal Dialysis Patients

By Karakan Sebnem   Sezer Siren   Özdemir Acar F. Nurhan   Haberal Mehmet  

Renal Failure, Vol. 34, Iss. 6, 2012-07 ,pp. : 732-737

Informa Healthcare

Access to resources Recommend Favorite